KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $5.5 billion.

  • Abbott Laboratories' Other Operating Expenses rose 632.74% to $5.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 billion, marking a year-over-year increase of 420.5%. This contributed to the annual value of $20.6 billion for FY2024, which is 322.45% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Other Operating Expenses is $5.5 billion, which was up 632.74% from $5.3 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Other Operating Expenses peaked at $5.5 billion during Q1 2022, and registered a low of $4.8 billion during Q1 2023.
  • In the last 5 years, Abbott Laboratories' Other Operating Expenses had a median value of $5.1 billion in 2023 and averaged $5.2 billion.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 4284.59% in 2021, then crashed by 1231.13% in 2023.
  • Abbott Laboratories' Other Operating Expenses (Quarter) stood at $5.3 billion in 2021, then fell by 3.62% to $5.1 billion in 2022, then fell by 1.02% to $5.0 billion in 2023, then grew by 7.35% to $5.4 billion in 2024, then grew by 1.63% to $5.5 billion in 2025.
  • Its last three reported values are $5.5 billion in Q3 2025, $5.3 billion for Q2 2025, and $4.9 billion during Q1 2025.